It is my long-term career goal to address the inefficiency of the one-size-fits-all cancer treatment paradigm by developing and demonstrating individualized treatment models that improve health outcomes. To this end, my overall research objectives relate to investigating predictors of anti-cancer drug response that can be used clinically to tailor drug treatment decisions and mitigate toxicity. Cancer treatments have some of the worst toxicities, many of which are directly related to elevated exposure. Interindividual variability in genetics and other factors like liver disease and drug-drug interactions explain why some patients have worse toxicity than others. My research as part of the Simon Comprehensive Cancer Center revolves around characterizing this variability to build predictive models that can be used clinically.
I have submitted my specific aims page and biosketch from my recently submitted K08 to further elaborate on my research interests towards predicting and reducing taxane toxicity.
Post-doctoral Fellowship - IU School of Medicine, Indianapolis, IN 05/2022
Pharm.D. - Butler University, Indianapolis, IN 05/2013
